Topical timolol prevented migrane attacks [8]

Eye

Volumn 18, Issue 7, 2004, Pages 751-

  Bhagey, J ^a   James, Bruce ^a  

^a STOKE MANDEVILLE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMIGRAINE AGENT; TIMOLOL;

ADULT; CASE REPORT; DISEASE ASSOCIATION; DISEASE DURATION; EYE PAIN; FEMALE; HUMAN; INTRAOCULAR HYPERTENSION; LETTER; MIGRAINE; NAUSEA AND VOMITING; PHOTOPHOBIA; TREATMENT FAILURE; TREATMENT OUTCOME;

EID: 4344578081     PISSN: 0950222X     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.eye.6701303     Document Type: Letter

References (7)

1. Van Buskirk EM. Adverse reaction from timolol administration. Ophthalmology 1980; 87(5): 447-450.
2. Ishikawa H, Yoshihara M, Mizuki K, Kashima Y. A pediatric case of ophthalmoplegic migraine with recurrent oculomotor nerve palsy. Jpn J Ophthalmol 2000; 44(5): 576.
3. Massiou H, Bousser MG. Beta-blockers and migraine. Pathol Biol 1992; 40(4): 373-380.
4. Tfelt-Hansen P. Efficacy of beta-blockers in migraine. A critical review. Cephalagia 1986; 6(Suppl. 5): 15-24.
5. Pfaffenrath V, Pollman W, Kufner G, Drubba S. Migraine and beta-blocker. An overview. Fortschr Neurol-Psychiatrie 1985; 53(1): 13-21.
6. Anderson KE, Vine E. Beta-adrenoceptor blockers and calcium antagonists in the prophylaxis and treatment of migraine. Drugs 1990; 39(3): 355-373.
7. Shedden AH, Laurence J, Barrish A, Olah TV. Plasma timolol concentrations of timolol maleate: timolol gel-forming solution (TIMOPTIC-XE) once daily versus timolol maleate ophthalmic solution twice daily. Documenta Ophthalmol 2001; 103(1): 73-79.